Friday March 23, 2018

Researchers have found a way to preserve fertility in female cancer survivors

Study shows that about 43-62 percent had unmet information needs about fertility and two-thirds of women were worried about their capability to give birth.

National Cancer Survivours Day. NCSD

A recent study has shown that many young female cancer survivors are not fully aware of information about how they are at high risk of early menopause and how to preserve their fertility after completing treatment.

About 43-62 percent women had unmet information needs and two-thirds of them were worried about their capability to give birth to a child in future. Researchers have stated that females thinking to have children are not yet ready to start a family and may have to undergo fertility preservation with egg or embryo freezing after treatment. Due to cancer, they are also at high risk of early menopause.

“Failure to provide information and address concerns with respect to fertility-related decisions may have lasting consequences for young women who hope to achieve important life goals such as having children,” said lead author Catherine Benedict from Northwell Health, New York State’s largest health care provider and private employer.

The paper published by Benedict in journal cancer also stated “For women are at risk of early menopause, delaying fertility-related decisions may cause them to miss their narrowed window of opportunity to preserve their fertility, if desired.”

The team wanted to understand about how young female cancer survivors view the decision of undergoing fertility preservation after treatment and to learn about their informational needs.

Woman with her new born. Image source: Wikimedia Commons
Woman with her newborn. Image source: Wikimedia Commons

Members of team examined around 346 participants whose age was about 30 years and they also researched on a subgroup of 179 women about women with certain fertility status who had not undergone the fertility preservation before.

The results showed that greater reproductive concerns and unmet information made it more difficult to think about the fertility preservation.

The findings in the study also established the need for creating support centres to help young female cancer survivors make decisions about fertility preservation and family-building as part of survivorship care.

This study also helped in understanding the importance and need of women making fertility decisions before treatment.

-by Bhaskar Raghavendran

Bhaskar is a graduate in Journalism and mass communication from Amity school of communication, Noida. Contact the author at Twitter: bhaskar_ragha

Related articles :

Click here for reuse options!
Copyright 2016 NewsGram

Next Story

A Protein That Can Stop Cancer?

The research showed that LHPP emerged as the top favourite. Pixabay

Researchers have discovered a protein that prevents the uncontrolled proliferation of cancer cells in the liver.

The anti-cancer protein, called LHPP, can also serve as a biomarker for the diagnosis and prognosis of liver cancer, said the study published in the journal Nature.

The incidence of liver cancer, also known as hepatocellular carcinoma, is usually diagnosed at a very late stage when the liver is already severely damaged and hence overall prognosis is poor.

ALSO READ: World Cancer Day special: Fight cancer with hope and positive attitude

The researchers believe that detection of the anti-cancer protein LHPP as a biomarker may allow clinicians to provide better treatment options.

“It is striking that LHPP is present in healthy tissue and completely absent in tumour tissue,” said first author Sravanth Hindupur from University of Basel in Switzerland. Pixabay


In the study conducted in a mouse model for hepatocellular carcinoma, the researchers analyzed a total of more than 4,000 proteins, comparing them in healthy and tumour tissue.

ALSO READ: How gut bacteria, broccoli can help keep colorectal cancer away

Re-introduction of the genetic information for LHPP by the researchers was found to prevent the formation of tumours and maintain liver function.

“Similar to the mouse model, we also saw a striking decrease in LHPP levels in tumours of patients with liver cancer,” Hindupur said. (IANS)